Removal and fate of emerging organic micropollutants (EOMs) in municipal wastewater by a pilot-scale membrane bioreactor (MBR) treatment under varying solid retention times

Insights into the efficiencies of different biological treatment systems for pharmaceuticals removal: A review

This review presents a comprehensive analysis of current research on biological treatment processes for removing pharmaceutical compounds (PhCs) from wastewater. Unlike previous studies on this topic, our study specifically delves into the effectiveness and drawbacks of various treatment approaches such as traditional wastewater treatment facilities (WWTP), membrane bioreactors (MBRs), constructed wetlands (CW), and moving bed biofilm reactors (MBBR). Through the examination and synthesis of information gathered from more than 200 research studies, we have created a comprehensive database that delves into the effectiveness of eliminating 19 particular PhCs, including commonly studied compounds such as acetaminophen, ibuprofen, diclofenac, naproxen, ketoprofen, indomethacin, salicylic acid, codeine, and fenoprofen, amoxicillin, azithromycin, ciprofloxacin, ofloxacin, tetracycline, atenolol, propranolol, and metoprolol. This resource provides a depth and scope of information that was previously lacking in this area of study. Notably, among these pharmaceuticals, azithromycin demonstrated the highest removal rates across all examined treatment systems, with the exception of WWTPs, while carbamazepine consistently exhibited the lowest removal efficiencies across various systems. The analysis showcases the diverse results in removal efficiency impacted by factors such as system configuration, operation specifics, and environmental circumstances. The findings emphasize the critical need for continued innovation and research, specifically recommending the integration of advanced oxidation processes (AOPs) with existing biological treatment methods to improve the breakdown of recalcitrant compounds like carbamazepine. PRACTITIONER POINTS: Persistent pharmaceuticals harm aquatic ecosystems and human health. Biological systems show varying pharmaceutical removal efficiencies. Enhancing HRT and SRT improves removal but adds complexity and costs. Tailored treatment approaches needed based on contaminants and conditions.

Unveiling the influence of microaeration and sludge recirculation on enhancement of pharmaceutical removal and microbial community change of the novel anaerobic baffled biofilm - membrane bioreactor in treating building wastewater

This research aims to conduct a comparative investigation of the role played by microaeration and sludge recirculation in the novel anaerobic baffled biofilm-membrane bioreactor (AnBB-MBR) for enhancing pharmaceutical removal from building wastewater. Three AnBB-MBRs - R1: AnBB-MBR, R2: AnBB-MBR with microaeration and R3: AnBB-MBR with microaeration and sludge recirculation - were operated simultaneously to remove Ciprofloxacin (CIP), Caffeine (CAF), Sulfamethoxazole (SMX) and Diclofenac (DCF) from real building wastewater at the hydraulic retention time (HRT) of 30 h for 115 days. From the removal profiles of the targeted pharmaceuticals in the AnBB-MBRs, it was found that the fixed-film compartment (C1) could significantly reduce the targeted pharmaceuticals. The remaining pharmaceuticals were further removed with the microaeration compartment. R2 exhibited the utmost removal efficiency for CIP (78.0 %) and DCF (40.8 %), while SMX was removed most successfully by R3 (microaeration with sludge recirculation) at 91.3 %, followed by microaeration in R2 (88.5 %). For CAF, it was easily removed by all AnBB-MBR systems (>90 %). The removal mechanisms indicate that the microaeration in R2 facilitated the adsorption of CIP onto microaerobic biomass, while the enhanced biodegradation of CAF, SMX and DCF was confirmed by batch biotransformation kinetics and the adsorption isotherms of the targeted pharmaceuticals. The microbial groups involved in biodegradation of the targeted compounds under microaeration were identified as nitrogen removal microbials (Nitrosomonas, Nitrospira, Thiobacillus, and Denitratisoma) and methanotrophs (Methylosarcina, Methylocaldum, and Methylocystis). Overall, explication of the integration of AnBB-MBR with microaeration (R2) confirmed it as a prospective technology for pharmaceutical removal from building wastewater due to its energy-efficient approach characterized by minimal aeration supply.

Occurrence, fate, and ecological risk of antibiotics in wastewater treatment plants in China: A review

This review offers a comprehensive overview of the occurrence, fate, and ecological risk associated with six major categories of antibiotics found in influent, effluent, and sludge from urban wastewater treatment plants (WWTPs) in China. Further exploration includes examining the correlation between antibiotic residual rates in the effluents and process parameters of urban WWTPs across the country. Lastly, a nationwide and urban cluster-specific evaluation of the ecological risk posed by antibiotics in WWTPs is conducted. The findings reveal that the average concentrations of antibiotics in influent, effluent, and sludge from urban WWTPs in China are 786.2 ng/L, 311.2 ng/L, and 186.8 μg/kg, respectively. Among the detected antibiotics, 42% exhibit moderate to high ecological risk in the effluent, with ciprofloxacin, sulfamethoxazole, erythromycin, azithromycin, and tetracycline posing moderate to high ecological risks in sludge. The current biological treatment processes in WWTPs demonstrate inefficacy in removing antibiotics. Hence, there is a pressing need to develop and integrate innovative technologies, such as advanced oxidation processes. This review aims to offer a more comprehensive understanding and identify priority antibiotics for control to effectively manage antibiotic pollution within WWTPs at both national and regional levels.

A comparative study on performance of the conventional and fixed-bed membrane bioreactors for treatment of Naproxen from pharmaceutical wastewater

Here, a comparative study was designed to survey the treatment efficiency of pharmaceutical wastewater containing Naproxen by Membrane bioreactor (MBR) and MBR with fixed-bed packing media (FBMBR). To this end, the performance of MBR and FBMBR in different aeration conditions including average DO (1.9-3.8 mg/L), different organic loading (OLR) (0.86, 1.14 and 1.92 kg COD per cubic meter per day), and Naproxen removal efficiency. The BOD5 removal efficiency, effluent quality and membrane fouling were monitored within 140 days. The results obtained from the present study indicated that COD removal efficiency for FBMBR (96.46%) was higher than that for MBR (95.33%). In addition, a high COD removal efficiency was experienced in both MBR and FBMBR in operational conditions 3 and 4, even where OLR increased from 1.14 to 1.92 kgCOD/m3 d and DO decreased from 4 to < 1 mg/L. Furthermore, the higher Naproxen removal efficiency was observed in FBMBR (94.17%) compared to that for MBR (92.76%). Therefore, FBMBR is a feasible and promising method for efficient treatment of pharmaceuptical wastewater with high concentrations of emerging contaminant, especially, the Naproxen.

Quantitative structure-biotransformation relationships of organic micropollutants in aerobic and anaerobic wastewater treatments

Biotransformation is one of the dominant processes to remove organic micropollutants (OMPs) in wastewater treatment. However, studies on the role of molecular structure in determining the biotransformation rates of OMPs are limited. We evaluated the biotransformation of 14 OMPs belonging to different chemical classes under aerobic and anaerobic conditions, and then explored the quantitative structure-biotransformation relationships (QSBRs) of the OMPs based on biotransformation rates using valid molecular structure descriptors (electrical and physicochemical parameters). Pseudo-first-order kinetic modeling was used to fit the biotransformation rate, and only 2 of the 14 OMPs showed that the biotransformation rate constant (kbio) values were higher under anaerobic conditions than aerobic conditions, indicating that aerobic conditions were more favorable for biotransformation of most OMPs. QSBRs infer that the electrophilicity index (ω) is a reliable predictor for OMPs biotransformation under aerobic conditions. ω corresponds to the interaction between OMPs and microbial enzyme active sites, this process is the rate-limiting step of biotransformation. However, under anaerobic conditions the QSBR based on ω was not significant, indicating that specific functional groups may be more critical than electrophilicity. In conclusion, QSBRs can serve as alternative tools for the prediction of the biotransformation of OMPs and provide further insights into the factors that influence biotransformation.

Evaluating membrane bioreactor treatment for the elimination of emerging contaminants using different analytical methods

Since wastewater treatment plants (WWTPs) were not originally designed to eliminate contaminants of emerging concern (CECs), alternative strategies like membrane bioreactor (MBR) technology are gaining importance in achieving effective CEC removal and minimising their environmental impact. In this study, composite wastewater samples were collected from the biggest WWTP in the Basque Country (Galindo, Biscay) and the performance of two secondary treatments (i.e. conventional activated sludge treatment, CAS, and MBR) was assessed. The combination of a suspect screening approach using liquid chromatography tandem high-resolution mass spectrometry (LC-HRMS) and multitarget analysis by gas chromatography-mass spectrometry (GC-MS) allowed the detection of approximately 200 compounds in the WWTP effluents. The estimated removal efficiencies (REs) revealed that only 16 micropollutants exhibited enhanced removal by MBR treatment (RE > 70% or 40 - 60%). The environmental risk posed by the non-eliminated compounds after both treatments remained similar, being anthracene, clarithromycin, bis(2-ethylhexyl) phthalate (DEHP) and dilantin the most concerning pollutants (RQ > 1). The Microtox® bioassay confirmed the MBR's efficiency in removing baseline toxicity, while suggesting a similar performance of CAS treatment. These minimal differences between treatments call into question the worthiness of MBR treatment and emphasise the need to seek more efficient alternative treatment methods.

Ketoprofen as an emerging contaminant: occurrence, ecotoxicity and (bio)removal

Ketoprofen, a bicyclic non-steroidal anti-inflammatory drug commonly used in human and veterinary medicine, has recently been cited as an environmental contaminant that raises concerns for ecological well-being. It poses a growing threat due to its racemic mixture, enantiomers, and transformation products, which have ecotoxicological effects on various organisms, including invertebrates, vertebrates, plants, and microorganisms. Furthermore, ketoprofen is bioaccumulated and biomagnified throughout the food chain, threatening the ecosystem function. Surprisingly, despite these concerns, ketoprofen is not currently considered a priority substance. While targeted eco-pharmacovigilance for ketoprofen has been proposed, data on ketoprofen as a pharmaceutical contaminant are limited and incomplete. This review aims to provide a comprehensive summary of the most recent findings (from 2017 to March 2023) regarding the global distribution of ketoprofen in the environment, its ecotoxicity towards aquatic animals and plants, and available removal methods. Special emphasis is placed on understanding how ketoprofen affects microorganisms that play a pivotal role in Earth's ecosystems. The review broadly covers various approaches to ketoprofen biodegradation, including whole-cell fungal and bacterial systems as well as enzyme biocatalysts. Additionally, it explores the potential of adsorption by algae and phytoremediation for removing ketoprofen. This review will be of interest to a wide range of readers, including ecologists, microbiologists, policymakers, and those concerned about pharmaceutical pollution.

Predicting and improving the microbial removal of organic micropollutants during wastewater treatment: A review

Organic micropollutants (OMPs) consist of widely used chemicals such as pharmaceuticals and pesticides that can persist in surface and groundwaters at low concentrations (ng/L to μg/L) for a long time. The presence of OMPs in water can disrupt aquatic ecosystems and threaten the quality of drinking water sources. Wastewater treatment plants (WWTPs) rely on microorganisms to remove major nutrients from water, but their effectiveness at removing OMPs varies. Low removal efficiency might be the result of low concentrations, inherent stable chemical structures of OMPs, or suboptimal conditions in WWTPs. In this review, we discuss these factors, with special emphasis on the ongoing adaptation of microorganisms to degrade OMPs. Finally, recommendations are drawn to improve the prediction of OMP removal in WWTPs and to optimize the design of new microbial treatment strategies. OMP removal seems to be concentration-, compound-, and process-dependent, which poses a great complexity to develop accurate prediction models and effective microbial processes targeting all OMPs.

Fate and removal of iodinated X-ray contrast media in membrane bioreactor: Microbial dynamics and effects of different operational parameters

Iodinated X-ray contrast media (ICM) are mainly used in medical sector, and their presence in environmental waters is a cause of concern as they are capable of forming highly toxic iodinated disinfection byproducts. In the present study, the removal mechanisms of the three ICM- iohexol, iopromide, and iopamidol were elucidated in a lab-scale aerobic membrane bioreactor (MBR). At steady-state operation (solids retention time (SRT)- 70 days, organic loading rate (OLR)- 0.80 KgCOD/m³-day, nitrogen loading rate (NLR)- 0.08 KgNH₄-N/m³-day, hydraulic retention time (HRT)- 12 h), the average removal of iohexol and iopromide was found to be 34.9 and 45.2 %, respectively, whereas iopamidol proved to be highly recalcitrant in aerobic conditions of the MBR (removal <10 % in all phases of the MBR operation). Further, through batch kinetic studies and mass balance analysis, it was observed that ICM were primarily biotransformed in the MBR system and biosorption (K_d < 10 L/Kg) was negligible. The biodegradation rate coefficient values (K_biol) of the ICM were found to be <0.65 L/g-d which indicate that biotransformation rate of ICM was slow. Increased OLR (1.60 KgCOD/m³-day) and reduced SRT (20 days) were found to negatively affect the removal of the ICM. Further, the removal of ICM was found to depend on its initial concentration, and the increment in the ammonium loading (0.16 KgNH₄-N/m³-day) did not favor its removal. The dosing of ICM altered the microbial dynamics of the mixed liquor and reduced the microbial diversity and richness. Bdellovibrio, Zoogloea, and bacteria belonging to TM7-3 class, Cryomorphaceae and Hyphomonadaceae families may contribute in ICM biotransformation.

A step forward on site-specific environmental risk assessment and insight into the main influencing factors of CECs removal from wastewater

The presence of Contaminants of Emerging Concern (CECs) in water systems has been recognized as a potential source of risk for human health and the ecosystem. The present paper aims at evaluating the effects of different characteristics of full-scale Wastewater Treatment Plants (WWTPs) on the removal of 14 selected CECs belonging to the classes of caffeine, illicit drugs and pharmaceuticals. Particularly, the investigated plants differed because of the treatment lay-out, the type of biological process, the value of the operating parameters, the fate of the treated effluent (i.e. release into surface water or reuse), and the treatment capacity. The activity consisted of measuring concentrations of the selected CECs and also traditional water quality parameters (i.e. COD, phosphorous, nitrogen species and TSS) in the influent and effluent of 8 plants. The study highlights that biodegradable CECs (cocaine, methamphetamine, amphetamine, benzoylecgonine, 11-nor-9carboxy-Δ9-THC, lincomycin, trimethoprim, sulfamethoxazole, sulfadiazine, sulfadimethoxine, carbamazepine, ketoprofen, warfarin and caffeine) were well removed by all the WWTPs, with the best performance achieved by the MBR for antibiotics. Carbamazepine was removed at the lowest extent by all the WWTPs. The environmental risk assessed by using the site-specific value of the dilution factor resulted to be high in 3 out of 8 WWTPs for carbamazepine and less frequently for caffeine. However, the risk was reduced when the dilution factor was assumed equal to the default value of 10 as proposed by EU guidelines. Therefore, a specific determination of this factor is needed taking into account the hydraulic characteristics of the receiving water body.

Effects of high-strength landfill leachate effluent on stress-induced microalgae lipid production and post-treatment micropollutant degradation

This research investigates the effects of landfill leachate effluent concentrations from moving bed biofilm reactor (MBBR) on stress-induced Chlorella vulgaris and Scenedesmus armatus lipid production and post-treatment micropollutant degradation. The effluent concentrations were varied between 25%, 50%, 75%, and 100% (v/v). The landfill leachate influent was treated using two-stage moving bed biofilm reactor under 24 h and 18 h hydraulic retention time (HRT). The results indicated that the effluent concentration was positively correlated with the stress-induced microalgae lipid production in the post-treatment of residual micropollutants. C. vulgaris and S. armatus completely remove residual micropollutants in the effluent. The superoxide dismutase and peroxidase activity were positively correlated with the cellular lipid content. The lipid content of C. vulgaris and S. armatus cultivated in the 18 h HRT effluent were 31-51% and 51-64%, while those in the 24 h HRT effluent were 15-16% and 5-19%. The optimal condition of microalgae cultivation for the post-treatment of residual micropollutants was 50-75% (v/v) effluent concentrations under 18 h HRT, achieving the highest lipid production of 113-116 mg/L for C. vulgaris and 74-75 mg/L for S. armatus. Essentially, the MBBR landfill leachate effluent holds promising potential as a substrate for microalgae lipid production.

Wastewater toxicity removal: Integrated chemical and effect-based monitoring of full-scale conventional activated sludge and membrane bioreactor plants

The literature is currently lacking effect-based monitoring studies targeted at evaluating the performance of full-scale membrane bioreactor plants. In this research, a monitoring campaign was performed at a full-scale wastewater treatment facility with two parallel lines (traditional activated sludge and membrane bioreactor). Beside the standard parameters (COD, nitrogen, phosphorus, and metals), 6 polynuclear aromatic hydrocarbons, 29 insecticides, 2 herbicides, and 3 endocrine disrupting compounds were measured. A multi-tiered battery of bioassays complemented the investigation, targeting different toxic modes of action and employing various biological systems (uni/multicellular, prokaryotes/eukaryotes, trophic level occupation). A traffic light scoring approach was proposed to quickly visualize the impact of treatment on overall toxicity that occurred after the exposure to raw and concentrated wastewater. Analysis of the effluents of the CAS and MBR lines show very good performance of the two systems for removal of organic micropollutants and metals. The most noticeable differences between CAS and MBR occurred in the concentration of suspended solids; chemical analyses did not show major differences. On the other hand, bioassays demonstrated better performance for the MBR. Both treatment lines complied with the Italian law's "ecotoxicity standard for effluent discharge in surface water". Yet, residual biological activity was still detected, demonstrating the adequacy and sensitivity of the toxicological tools, which, by their inherent nature, allow the overall effects of complex mixtures to be taken into account.

Biochar enhances the biotransformation of organic micropollutants (OMPs) in an anaerobic membrane bioreactor treating sewage

The removal of emerging organic micropollutants (OMPs) in anaerobic membrane bioreactors (AnMBRs) has garnered considerable attention owing to the rapid development of AnMBR technology and the increased environmental risk caused by OMP discharge. We investigated the removal efficiency of 22 typical OMPs from sewage being treated in an AnMBR, and implemented and evaluated an upgrading strategy by adding biochar. The average removal efficiency of OMPs was only 76.8% due to hydrophilic OMPs containing electron-withdrawing groups (ketoprofen, ibuprofen, diclofenac, and carbamazepine) being poorly removed. Biochar addition (5.0 g/L) promoted the removal of recalcitrant OMPs by 45%, leading to an enhanced removal efficiency of 88.7%. Although biochar has a high adsorption capacity to different OMPs, the biotransformation rather than sorption removal efficiency of 13 of the 22 OMPs was largely enhanced, suggesting that adsorption-biotransformation was the main approach by which biochar enhances the OMP removal. Biotransformation test and microbial analysis revealed that the enrichment of species (Flavobacterium, Massilia, Acinetobacter, and Cloacibacterium) involved in OMP biotransformation on biochar contributed largely to the enhanced biotransformation removal efficiency of OMPs. In this way, the enhanced electron transfer activity and syntrophic metabolism between hydrogenotrophic methanogens and species that oxidize acetate to H₂/CO₂ on biochar jointly contributed to the stable CH₄ production and OMP biotransformation. This study provides a promising strategy to enhance the OMP removal in AnMBRs and improves our understanding of the underlying mechanism of biochar-amended OMP removal in anaerobic treatment systems.

Rejection of trace organic compounds by membrane processes: mechanisms, challenges, and opportunities

This work critically reviews the application of various membrane separation processes (MSPs) in treating water polluted with trace organic compounds (TOrCs) paying attention to nanofiltration (NF), reverse osmosis (RO), membrane bioreactor (MBR), forward osmosis (FO), and membrane distillation (MD). Furthermore, the focus is on loopholes that exist when investigating mechanisms through which membranes reject/retain TOrCs, with the emphasis on the characteristics of the model TOrCs which would facilitate the identification of all the potential mechanisms of rejection. An explanation is also given as to why it is important to investigate rejection using real water samples, especially when aiming for industrial application of membranes with novel materials. MSPs such as NF and RO are prone to fouling which often leads to lower permeate flux and solute rejection, presumably due to cake-enhanced concentration polarisation (CECP) effects. This review demonstrates why CECP effects are not always the reason behind the observed decline in the rejection of TOrCs by fouled membranes. To mitigate for fouling, researchers have often modified the membrane surfaces by incorporating nanoparticles. This review also attempts to explain why nano-engineered membranes have not seen a breakthrough at industrial scale. Finally, insight is provided into the possibility of harnessing solar and wind energy to drive energy intensive MSPs. Focus is also paid into how low-grade energy could be stored and applied to recover diluted draw solutions in FO mode.

Diclofenac removal from the wastewater using activated sludge and analysis of multidrug resistant bacteria from the sludge

Diclofenac is an anti-inflammatory drug and has been frequently detected from the wastewater. In the present study, factors affecting diclofenac adsorption on sewage sludge was evaluated. At 1 mg/L initial diclofenac concentration, more than 80% diclofenac removal was achieved. Adsorption increased at higher concentration (100 mg/L concentration) and more than 99% diclofenac was adsorbed from the wastewater. Significant removal of diclofenac was observed after 5 min contact time. The adsorption efficacy was more than 98% after 50 and 60 min. Pseudo-first and second order kinetics revealed reasonable regression value (0.9) indicated that the model is best fitted. Diclofenac adsorption was extremely high at acidic pHs than alkaline range. The sludge samples showed the presence of multi drug resistant bacteria. Vancomycin-resistant enterococcus stains were 27%, Methicillin-resistant Staphylococcus aureus positive strains were 16.5% and Extended-spectrum betal-lactamase-harbouring Enterobacteriacea were 65.4% in the sludge. The drug resistance Enterobacteriaceae revealed 14 Klebsiella pneumonia strains, 11 strains from E. coli and two from the genus Enterobacter. To conclude, the activated sludge could be effectively utilized for the removal of diclofenac from wastewater.

Effects of pharmaceuticals on membrane bioreactor: Review on membrane fouling mechanisms and fouling control strategies

Pharmaceuticals have become contaminants of emerging concern due to their toxicity towards aquatic life and pseudo persistent nature in the environment. Membrane bioreactor (MBR) is one such technology that has the potential to act as a barrier against the release of pharmaceuticals into the environment. Fouling is the deposition of the constituents of the mixed liquor on the membrane surface and it limit the world-wide applicability of MBRs. To remove foulant layer, aggressive chemicals and extra cost consideration in terms of energy are required. Extracellular polymeric substances (EPS) and soluble microbial products (SMP) are recognized as principal foulants. Presence of pharmaceuticals has been found to increase the fouling in MBRs. Fouling aggravates in proportion to the concentration of pharmaceuticals. Pharmaceuticals exert chemical stress in microbes, hence forcing them to secrete more EPS/SMP. Pharmaceuticals alter the composition of the foulants and affect microbial metabolism, thereby inflicting direct/indirect effects on fouling. Pharmaceuticals have been found to increase or decrease the size of sludge flocs, however the exact mechanism that govern the floc size change is yet to be understood. Different techniques such as coupling advanced oxidation processes with MBR, adding activated carbon, bioaugmenting MBR with quorum quenching strains have shown to reduce fouling in MBRs treating pharmaceutical wastewater. These fouling mitigation techniques work on reducing the EPS/SMP concentration, thereby alleviating fouling. The present review provides a comprehensive understanding of the effects induced by pharmaceuticals in the activated sludge characteristics and identifying the fouling mechanism. Furthermore, significant knowledge gaps and recent advances in fouling mitigation strategies are discussed. This review has also made an effort to highlight the positive aspect of the foulant layer in retaining pharmaceuticals and antibiotic resistance genes, thereby suggesting a possible delicate trade-off between the flux decline and enhanced removal of pharmaceuticals.

Dynamics of microbial community and their effects on membrane fouling in an anoxic-oxic gravity-driven membrane bioreactor under varying solid retention time: A pilot-scale study

Membrane fouling in a membrane bioreactor (MBR) is highly influenced by the characteristics of the influent, the mixed liquor microbial community and the operational parameters, all of which are environment specific. Therefore, we studied the dynamics of microbial community during the treatment of real municipal wastewater in a pilotscale anoxic-oxic (A/O) MBR equipped with a gravity-driven membrane filtration system. The MBR was operated at three different solid retention times (SRTs): 25, 40 and 10 days for a total period of 180 days in Nordic environmental conditions. Analysis of microbial community dynamics revealed a high diversity of microbial species at SRT of 40 days, whereas SRT of 25 days was superior with microbial richness. Production of soluble microbial products (SMP) and extracellular polymeric substances (EPS) was found to be intensely connected with the SRT and food to microorganism (F/M) ratio. Relatively longer operational period with the lowest rate of membrane fouling was observed at SRT of 25 days, which was resulted from the superior microbial community, lowest production of SMP and loosely bound EPS as well as the lower filtration resistance of larger sludge flocs. Abundance of quorum quenching (QQ) bacteria and granular floc forming bacterial genera at SRT of 25 days provided relatively lower membrane fouling tendency and larger floc formation, respectively. On the other hand, substantial amount of various surface colonizing and EPS producing bacteria was found at SRT of 10 days, which promoted more rapid membrane fouling compared with the fouling rate seen at other tested SRTs. To sum up, this research provides a realistic insight into the impact of SRT on microbial community dynamics and resulting characteristics of mixed liquor, floc size distribution and membrane fouling for improved MBR operation.

Strategies to enhance micropollutant removal from wastewater by membrane bioreactors: Recent advances and future perspectives

Membrane bioreactor (MBR) has been widely implemented to advance wastewater treatment and reuse. Nevertheless, conventional MBRs with porous microfiltration or ultrafiltration membranes are not designed for the removal of micropollutants, which ubiquitously occur in wastewater at trace concentrations, but potentially exert detrimental impacts to the ecosystem. Several effective strategies have been applied to improve MBR performance for micropollutant removal, particularly the hydrophilic and recalcitrant compounds. These strategies mainly include the optimization of operational conditions, employment of high-retention membranes to replace porous ones, addition of functional materials into bioreactor, and integration of effluent purification processes. In particular, effluent purification by advanced oxidation processes (AOPs) and high-retention membranes can complement MBR to secure almost complete removal of micropollutants. Nevertheless, further research is still necessary to evaluate the technical and economic feasibility of these strategies, especially for long-term treatment performance, to screen the suitable techniques for industrial MBR applications.

Removal of personal care products in greywater using membrane bioreactor and constructed wetland methods

Personal care products (PCPs) are contaminants of emerging concern because of their continuous input into the environment. In this study, membrane bioreactor (MBR) and constructed wetland (CW) methods were used to investigate the effect and mechanism of conventional pollutant and PCP removal from greywater. The effluent of both the MBR- and CW-treated greywater met the reclaimed water reuse standard in China. Conventional pollutants and five target PCPs had a higher removal efficiency in the MBR than in the CW. The removal rates of the PCPs, including Tuina musk (AHTN), were >80% using MBR and CW methods. The main pathway of removing PCPs in the MBR was sludge adsorption and biodegradation, whereas the contribution of the membrane module was weak. The main pathway of removing PCPs in the CW was the combined action of plant absorption, microbial biodegradation, and substrate adsorption, depending on the PCP type. Ethyl hexyl methoxycinnamate (EHMC) has strong biological oxidizability and was mainly removed by biodegradation, whereas Jiale musk (HHCB) and AHTN were mainly removed by adsorption. Six types of CW substrates were investigated, and perlite showed the best adsorption effect for the five target PCPs. The optimal substrate adsorption pH was 7. This study provides important technical information on the effective removal of conventional pollutants and PCPs in greywater and the preparation of high-quality reclaimed water.

Effect of concentration and hydraulic reaction time on the removal of pharmaceutical compounds in a membrane bioreactor inoculated with activated sludge

Pharmaceuticals are often not fully removed in wastewater treatment plants (WWTPs) and are thus being detected at trace levels in water bodies all over the world posing a risk to numerous organisms. These organic micropollutants (OMPs) reach WWTPs at concentrations sometimes too low to serve as growth substrate for microorganisms; thus, co-metabolism is thought to be the main conversion mechanism. In this study, the microbial removal of six pharmaceuticals was investigated in a membrane bioreactor at increasing concentrations (4-800 nM) of the compounds and using three different hydraulic retention times (HRT; 1, 3.5 and 5 days). The bioreactor was inoculated with activated sludge from a municipal WWTP and fed with ammonium, acetate and methanol as main growth substrates to mimic co-metabolism. Each pharmaceutical had a different average removal efficiency: acetaminophen (100%) > fluoxetine (50%) > metoprolol (25%) > diclofenac (20%) > metformin (15%) > carbamazepine (10%). Higher pharmaceutical influent concentrations proportionally increased the removal rate of each compound, but surprisingly not the removal percentage. Furthermore, only metformin removal improved to 80-100% when HRT or biomass concentration was increased. Microbial community changes were followed with 16S rRNA gene amplicon sequencing in response to the increment of pharmaceutical concentration: Nitrospirae and Planctomycetes 16S rRNA relative gene abundance decreased, whereas Acidobacteria and Bacteroidetes increased. Remarkably, the Dokdonella genus, previously implicated in acetaminophen metabolism, showed a 30-fold increase in abundance at the highest concentration of pharmaceuticals applied. Taken together, these results suggest that the incomplete removal of most pharmaceutical compounds in WWTPs is dependent on neither concentration nor reaction time. Accordingly, we propose a chemical equilibrium or a growth substrate limitation as the responsible mechanisms of the incomplete removal. Finally, Dokdonella could be the main acetaminophen degrader under activated sludge conditions, and non-antibiotic pharmaceuticals might still be toxic to relevant WWTP bacteria.

Comparative overview of advanced oxidation processes and biological approaches for the removal pharmaceuticals

Nowadays, pharmaceuticals are the center of significant environmental research due to their complex and highly stable bioactivity, increasing concentration in the water streams and high persistence in aquatic environments. Conventional wastewater treatment techniques are generally inadequate to remove these pollutants. Aiming to tackle this issue effectively, various methods have been developed and investigated on the light of chemical, physical and biological procedures. Increasing attention has recently been paid to the advanced oxidation processes (AOPs) as efficient methods for the complete mineralization of pharmaceuticals. Their high operating costs compared to other processes, however, remain a challenge. Hence, this review summarizes the current and state of art related to AOPs, biological treatment and their effective exploitation for the degradation of various pharmaceuticals and other emerging molecules present in wastewater. The review covers the last decade with a particular focus on the previous five years. It is further envisioned that this review of advanced oxidation methods and biological treatments, discussed herein, will help readers to better understand the mechanisms and limitations of these methods for the removal of pharmaceuticals from the environment. In addition, we compared AOPs and biological treatments for the disposal of pharmaceuticals from the point of view of cost, effectiveness, and popularity of their use. The exploitation of coupling AOPs and biological procedures for the degradation of pharmaceuticals in wastewater was also presented. It is worthy of note that an integrated AOPs/biological system is essential to reach the complete degradation of pharmaceuticals; other advantages of this hybrid technique involve low energy cost, an efficient degradation process and generation of non-toxic by-products.

Comprehensive review on iodinated X-ray contrast media: Complete fate, occurrence, and formation of disinfection byproducts

Iodinated contrast media (ICM) are drugs which are used in medical examinations for organ imaging purposes. Wastewater treatment plants (WWTPs) have shown incapability to remove ICM, and as a consequence, ICM and their transformation products (TPs) have been detected in environmental waters. ICM show limited biotransformation and low sorption potential. ICM can act as iodine source and can react with commonly used disinfectants such as chlorine in presence of organic matter to yield iodinated disinfection byproducts (IDBPs) which are more cytotoxic and genotoxic than conventionally known disinfection byproducts (DBPs). Even highly efficient advanced treatment systems have failed to completely mineralize ICM, and TPs that are more toxic than parent ICM are produced. This raises issues regarding the efficacy of existing treatment technologies and serious concern over disinfection of ICM containing waters. Realizing this, the current review aims to capture the attention of scientific community on areas of less focus. The review features in depth knowledge regarding complete environmental fate of ICM along with their existing treatment options.

Electrocatalysis degradation of tetracycline in a three-dimensional aeration electrocatalysis reactor (3D-AER) with a flotation-tailings particle electrode (FPE): Physicochemical properties, influencing factors and the degradation mechanism

Novel particle electrodes, i.e. flotation tailings particle electrode (FPE), were prepared using flotation tailings, garden soil, and soluble starch with a mass ratio of 16:3:1, and then used in tetracycline wastewater treatment. The physicochemical properties of FPE were systematically characterized using SEM, XRD, FT-IR and XRF. Tetracycline adsorption and its adsorption mechanism onto FPE was explored for the first time. Parameters affecting FPE's degradation efficiency and energy consumption such as current density, electrolysis time, initial concentration, initial pH and aeration rate were examined. The electrocatalytic degradation of tetracycline shows that the degradation of tetracycline meets the pseudo-first-order kinetics. Moreover, the numbers of •OH produced on the surfaces of the cathode, anode and particle electrode were compared. Results showed that the adsorption-saturated FPE can be regenerated by electrochemical action to induce further absorption and form in-situ electrocatalysis. In order to find out the transformation products in water and degradation pathways of Tetracycline, UHPLC method was used to obtain the degradation pathways for Tetracycline. So, this work could provide a fabrication of high-efficiency and low-cost electrocatalytic for removal of pharmaceuticals pollutants from waste water as well as deeper insight into electrocatalytic mechanism, transformation products, and degradation pathways of Tetracycline in water.

Biodegradation of Emerging Pharmaceuticals from Domestic Wastewater by Membrane Bioreactor: The Effect of Solid Retention Time

Although conventional biological treatment plants can remove basic pollutants, they are ineffective at removing recalcitrant pollutants. Membrane bioreactors contain promising technology and have the advantages of better effluent quality and lower sludge production compared to those of conventional biological treatment processes. In this study, the removal of pharmaceutical compounds by membrane bioreactors under different solid retention times (SRTs) was investigated. To study the effect of SRT on the removal of emerging pharmaceuticals, the levels of pharmaceuticals were measured over 96 days for the following retention times: 20, 30, and 40-day SRT. It was found that the 40-day SRT had the optimum performance in terms of the pharmaceuticals’ elimination. The removal efficiencies of the chemical oxygen demand (COD) for each selected SRT were higher than 96% at steady-state conditions. The highest degradation efficiency was observed for paracetamol. Paracetamol was the most removed compound followed by ranitidine, atenolol, bezafibrate, diclofenac, and carbamazepine. The microbial community at the phylum level was also analyzed to understand the biodegradability of pharmaceuticals. It was noticed that the Proteobacteria phylum increased from 46.8% to 60.0% after 96 days with the pharmaceuticals. The Actinobacteria class, which can metabolize paracetamol, carbamazepine, and atenolol, was also increased from 9.1% to 17.9% after adding pharmaceuticals. The by-products of diclofenac, bezafibrate, and carbamazepine were observed in the effluent samples.

Ethinylestradiol removal of membrane bioreactor effluent by reverse osmosis and UV/H2O2: A technical and economic assessment

Synthetic hormone 17α-ethinylestradiol (EE2) is not completely removed by conventional wastewater treatment plants and therefore is often detected in surface and groundwater, sludge and sediments. Due to its persistence in the environment and its estrogenic potential, a high removal of EE2 from wastewaters before its disposal has become a concern from an environmental point of view, particularly when considering urban reuse applications. This work investigated the application of advanced processes to treat synthetic municipal wastewater containing EE2 after treatment in a membrane bioreactor (MBR). Two advanced processes were assessed: the first is advanced oxidation process (AOP), using hydrogen peroxide (H₂O₂) and ultraviolet (UV) light (route MBR-AOP) and the second, reverse osmosis (RO), in this case using UV/H₂O₂ to treat the retentate from RO (route MBR-RO). EE2 concentration in final effluent was one order of magnitude lower in route MBR-AOP than in route MBR-RO. Implications for disposal or water reuse were discussed considering the importance of other water quality parameters as well. Economic estimates for CAPEX, OPEX and total cost were made. The introduction of the oxidative step (UV/H₂O₂) after MBR caused an increase in the total cost of US$ 0.39/m³. In turn, route MBR-RO increased the total process cost by US$ 0.86/m³, showing that reduction of volume to be treated by UV/H₂O₂ in this route did not offset the cost associated with the acquisition and operation of RO. The total cost was estimated at US$ 2.47/m³ for MBR-AOP and US$ 2.94/m³ for MBR-RO for a design flow of 10 m³/h.

Contaminants of Emerging Concern in African Wastewater Effluents: Occurrence, Impact and Removal Technologies

Worldwide, the pollution of water bodies by contaminants of emerging concern (CECs) such as pharmaceuticals, endocrine disrupting compounds, flame retardants including brominated flame retardants (BFRs) and perfluorochemicals (PFCs), micro plastics, nanomaterials, and algal toxins, to name just a few, is creating a new set of challenges to the conventional wastewater treatment facilities, which demonstrate inefficiency in removing/degrading many CECs. As a consequence, environmentalists started to detect the presence of some of those contaminants at alarming levels in certain countries, with possible negative effects on aquatic species and often increased potential for human health risks through the exposure to the contaminated waters, or the reuse of treated wastewater in agriculture and household use. Such issues are more accentuated in the African continent due to various socio-economic problems giving rise to poor sanitation systems and serious shortages in wastewater treatment plants in many regions, making it difficult to tackle the problem of conventional pollutants, let alone to deal with the more challenging CECs. Thus, in order to effectively deal with this emerging environmental threat, African researchers are working to develop and optimize sound sampling and analytical procedures, risk assessment models, and efficient remediation technologies. In this review, related recent research efforts conducted in African universities and research institutions will be presented and discussed with respect to the occurrence and assessment of CECs in African wastewater effluents, the potential risks to aquatic ecosystems and humans, the tailored remediation techniques, along with some knowledge gaps and new research directions.

A sustainability anti-infective pharmaceutical wastewater treatment technology: multi-stage vertical variable diameter membrane bioreactor with DO online controlling

The proper choice of dissolved oxygen (DO) is important in aerobic treatment. In this paper, a multi-stage vertical variable diameter membrane bioreactor was developed to treat pharmaceutical wastewater containing 6-APA and ceftriaxone sodium. In the 180 days of operation, the performance of COD, BOD₅, 6-APA, ceftriaxone sodium removal, sludge index, and microbial enzyme activity under different DOs (from 0.5 to 6.0 mg/L) were investigated. The results showed that the optimal range of DO was 1.5-2.1 mg/L, and the highest removal rates of COD and BOD₅ were observed 87.3%±2.4% and 95.3%±1.8%, the corresponding effluent COD and BOD₅ were 189 mg/L and 24 mg/L, respectively. To reduce the energy consumption and ensure stability of DO in the reactor, a control strategy based on an improved differential evolution BP fuzzy neural network was built and found that the performance and cost of the controlled DO were improved effectively than that of uncontrolled DO.

From Laboratory Tests to the Ecoremedial System: The Importance of Microorganisms in the Recovery of PPCPs-Disturbed Ecosystems

The presence of a wide variety of emerging pollutants in natural water resources is an important global water quality challenge. Pharmaceuticals and personal care products (PPCPs) are known as emerging contaminants, widely used by modern society. This objective ensures availability and sustainable management of water and sanitation for all, according to the 2030 Agenda. Wastewater treatment plants (WWTP) do not always mitigate the presence of these emerging contaminants in effluents discharged into the environment, although the removal efficiency of WWTP varies based on the techniques used. This main subject is framed within a broader environmental paradigm, such as the transition to a circular economy. The research and innovation within the WWTP will play a key role in improving the water resource management and its surrounding industrial and natural ecosystems. Even though bioremediation is a green technology, its integration into the bio-economy strategy, which improves the quality of the environment, is surprisingly rare if we compare to other corrective techniques (physical and chemical). This work carries out a bibliographic review, since the beginning of the 21st century, on the biological remediation of some PPCPs, focusing on organisms (or their by-products) used at the scale of laboratory or scale-up. PPCPs have been selected on the basics of their occurrence in water resources. The data reveal that, despite the advantages that are associated with bioremediation, it is not the first option in the case of the recovery of systems contaminated with PPCPs. The results also show that fungi and bacteria are the most frequently studied microorganisms, with the latter being more easily implanted in complex biotechnological systems (78% of bacterial manuscripts vs. 40% fungi). A total of 52 works has been published while using microalgae and only in 7% of them, these organisms were used on a large scale. Special emphasis is made on the advantages that are provided by biotechnological systems in series, as well as on the need for eco-toxicological control that is associated with any process of recovery of contaminated systems.

Emission and fate of antibiotics in the Dongjiang River Basin, China: Implication for antibiotic resistance risk

Antibiotics used for human and veterinary purposes are released into the environment, resulting in potential adverse effects, including the development and spread of antibiotic resistant bacteria. Here we investigated the dynamic fate of 36 antibiotics in a large river basin Dongjiang in South China, and discussed their potential antibiotic resistance selection risk. Based on the usage, excretion rate, wastewater treatment rate, human population and animal numbers the emissions of 36 frequently detected antibiotics were estimated for the Dongjiang River Basin. The total usage of the 36 antibiotics in the basin was 623.4 tons, which included 37% for human use and the rest for veterinary purposes. After being metabolized and partially treated, the amount of antibiotics excreted and released into the environment decreased to 267.6 tons. By allocating the high-precision antibiotic discharge inventory to 42 sewage plants and 17 livestock farms, an improved GREAT-ER (Geography referenced Regional Exposure Assessment Tool for European Rivers) model for the Dongjiang River Basin, with a well calibration river flow network based on the SWAT (Soil and Water Assessment Tool), was established to simulate the dynamic fate of 36 antibiotics. The simulation results showed that antibiotics contaminated >50% of the river sections. The modelled concentrations in water were almost within an order of magnitude of the measured concentrations. Antibiotic contamination in the dry season was obviously higher than that in the wet season. The concentrations of the antibiotics were always higher at the discharge zones and lower reaches of the river basin than the other reaches. The antibiotic resistance risk assessment showed that 23 out of the 36 antibiotics (nearly 65%) could pose high risks in the river basin. For those river reaches with high risks, the risk levels could mostly be reduced to low risk levels with a certain distance (15 km) from the pollution source. Therefore, more attention should be paid to those impact zones in term of antibiotic resistance.

Effects of carrier addition on water quality and pharmaceutical removal capacity of a membrane bioreactor - Advanced oxidation process combined treatment

This research was performed to assess the production of reclaimed water from urban wastewater in membrane bioreactor - advanced oxidation process (MBR-AOP) and moving bed biofilm reactor - membrane bioreactor - advanced oxidation process (MBBR-MBR-AOP) combined treatments to study the effect of biofilm incorporation. Both combined treatments were operated at the same conditions (10 h of hydraulic retention time, 6500 mg/L of mixed liquor suspended solids and 25 mg/L of hydrogen peroxide dosage over 15 min). Additionally, the removal capacity of some pharmaceuticals (carbamazepine, ciprofloxacin and ibuprofen) and their impact on the kinetic behaviour of the biomass in both systems were evaluated. From the results, it was found a membrane-based bioreactor can achieve both wastewater secondary treatment and pre-treatment for advanced oxidation process, so both MBR-AOP and MBBR-MBR-AOP treatments have a great potential to produce high quality reclaimed water (biological oxygen demand <0.5 mgO₂/L, suspended solids <1 mg/L, turbidity <1 NTU and no presence of E. coli), according to European Commission proposal 2018/0169/COD. The addition of carriers improved the biodegradation of the most persistent pharmaceuticals in the biological treatment (from 69.20 ± 1.54% to 75.14 ± 2.71% for carbamazepine and from 60.41 ± 2.16 to 63.14 ± 2.70% for ciprofloxacin). It had, as a consequence, the MBBR-MBR-AOP system showing a complete degradation of pharmaceuticals after 5 min AOP treatment compared to the MBR-AOP system. The loss of biomass in the MBR-AOP (from 5233.45 to 4451.92 mg/L) and the increase of the substrate degradation rate for organic matter in both treatments (from 37.27 to 41.42 and from 30.25 to 33.19 mgO₂/(L·h) in MBR-AOP and MBBR-MBR-AOP, respectively) are some of the consequences of pharmaceuticals in urban wastewater.

Distribution and Removal of Pharmaceuticals in Liquid and Solid Phases in the Unit Processes of Sewage Treatment Plants

In this study, we analyzed 27 pharmaceuticals in liquid and solid phase samples collected from the unit processes of four different sewage treatment plants (STPs) to evaluate their distribution and behavior of the pharmaceuticals. The examination of the relative distributions of various categories of pharmaceuticals in the influent showed that non-steroidal anti-inflammatory drugs (NSAIDs) were the most dominant. While the relative distribution of antibiotics in the influent was not high (i.e., 3%–5%), it increased to 14%–30% in the effluent. In the four STPs, the mass load of the target pharmaceuticals was reduced by 88%–95% mainly in the biological treatment process, whereas the ratio of pharmaceuticals in waste sludge to those in the influent (w/w) was only 2%. In all the STPs, the removal efficiencies for the stimulant caffeine, NSAIDs (acetaminophen, naproxen, and acetylsalicylic acid), and the antibiotic cefradine were high; they were removed mainly by biological processes. Certain compounds, such as the NSAID ketoprofen, contrast agent iopromide, lipid regulator gemfibrozil, and antibiotic sulfamethoxazole, showed varying removal efficiencies depending on the contribution of biodegradation and sludge sorption. In addition, a quantitative meta-analysis was performed to compare the pharmaceutical removal efficiencies of the biological treatment processes in the four STPs, which were a membrane bioreactor (MBR) process, sequencing batch reactor (SBR) process, anaerobic–anoxic–oxic (A2O) process, and moving-bed biofilm reactor (MBBR) process. Among the biological processes, the removal efficiency was in the order of MBR > SBR > A2O > MBBR. Among the tertiary treatment processes investigated, powdered activated carbon showed the highest removal efficiency of 18%–63% for gemfibrozil, ibuprofen, ketoprofen, atenolol, cimetidine, and trimethoprim.

Impact of hydraulic retention time and organic matter concentration on side-stream aerobic granular membrane bioreactor

This study investigated the effect of hydraulic retention time (HRT) and chemical oxygen demand (COD) concentration on membrane fouling in aerobic granular membrane bioreactor (AGMBR) in a systematic approach. Changes in HRT (7, 10, and 15 h) and COD (500, 1000 and 1500 mg/L) were applied in five operational phases, to determine the most significant parameters to control membrane fouling for enhanced AGMBR performance. Membrane permeability loss was dramatically intensified with increase in HRT from 7.5 to 15 h and COD from 500 to 1000 mg/L. The highest polysaccharide content of loosely bound EPS (0.41 mg PS/mg VSS) and soluble microbial products (SMPs) (27 mg PS/L) occurred alongside poor AGMBR performance. Variations in membrane fouling were accompanied with considerable changes in Flavobacterium, Thauera and Paracoccus populations. Analysis of variance (ANOVA) demonstrated that HRT and interaction between HRT and COD were the most significant parameters in controlling membrane fouling.